Quantum Cyber N.V. Increase Decrease Through Exercise Of Warrants Equity
Quantum Cyber N.V. (QUCY) reported Increase Decrease Through Exercise Of Warrants Equity of $382.50 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2025-03-31
- Quantum Cyber N.V. increase decrease through exercise of warrants equity for the quarter ending 2022-06-30 was $124.16K.
- Quantum Cyber N.V. increase decrease through exercise of warrants equity for the quarter ending 2022-03-31 was $258.34K.
| Period end | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|
| 2022-12-31 | $382.50K 20-F · filed 2025-03-31 | ||
| 2022-06-30 | $124.16K 6-K · filed 2023-11-16 | $382.50K 6-K · filed 2022-09-07 | |
| 2022-03-31 | $258.34K 6-K · filed 2023-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |